Investments
126Portfolio Exits
31Funds
5Service Providers
1About Longitude Capital
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. The Firm's growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile and attractive expected returns within three to five years from initial investment. Additionally, Longitude Capital utilizes a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties and other equity and equity-linked instruments.
Longitude Capital Headquarters Location
800 El Camino Real Suite 220
Menlo Park, California, 94025,
United States
650-854-5700
Expert Collections containing Longitude Capital
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Longitude Capital in 1 Expert Collection, including Conference Exhibitors.
Conference Exhibitors
5,302 items
Latest Longitude Capital News
Apr 7, 2022
IntelyCare, a Quincy, Mass.-based tech-enabled nurse staffing platform for healthcare organizations, secured USD 115m in Series C financing. The round, which valued IntelyCare at USD 1.1 billion, was led by Janus Henderson Investors with participation from Longitude Capital, Leeds Illuminate, Endeavour Vision, Revelation Partners, and Kaiser Permanente Ventures.
Longitude Capital Investments
126 Investments
Longitude Capital has made 126 investments. Their latest investment was in IntelyCare as part of their Series C on April 4, 2022.
Longitude Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/6/2022 | Series C | IntelyCare | $115M | Yes | 4 | |
4/5/2022 | Series D | LimFlow | $40M | Yes | 2 | |
3/15/2022 | Series A | On Belay Health Solutions | $6.54M | Yes | 1 | |
2/23/2022 | Series E | |||||
2/18/2022 | Series D |
Date | 4/6/2022 | 4/5/2022 | 3/15/2022 | 2/23/2022 | 2/18/2022 |
|---|---|---|---|---|---|
Round | Series C | Series D | Series A | Series E | Series D |
Company | IntelyCare | LimFlow | On Belay Health Solutions | ||
Amount | $115M | $40M | $6.54M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 4 | 2 | 1 |
Longitude Capital Portfolio Exits
31 Portfolio Exits
Longitude Capital has 31 portfolio exits. Their latest portfolio exit was Amunix on December 21, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
12/21/2021 | Acquired | 10 | |||
10/7/2021 | IPO | Public | 11 | ||
7/30/2021 | IPO | Public | 2 | ||
Date | 12/21/2021 | 10/7/2021 | 7/30/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 10 | 11 | 2 |
Longitude Capital Acquisitions
2 Acquisitions
Longitude Capital acquired 2 companies. Their latest acquisition was Ajax Vascular on November 26, 2014.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
11/26/2014 | Series A | $1.5M | Asset Sale | |||
8/20/2014 | Debt |
Date | 11/26/2014 | 8/20/2014 |
|---|---|---|
Investment Stage | Series A | Debt |
Companies | ||
Valuation | ||
Total Funding | $1.5M | |
Note | Asset Sale | |
Sources |
Longitude Capital Fund History
5 Fund Histories
Longitude Capital has 5 funds, including Longitude Capital Prime Fund I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
7/20/2021 | Longitude Capital Prime Fund I | $135M | 1 | ||
9/23/2020 | Longitude Venture Partners IV | ||||
6/7/2016 | Longitude Venture Partners III | ||||
10/22/2012 | Longitude Venture Partners II | ||||
6/16/2008 | Longitude Venture Partners |
Closing Date | 7/20/2021 | 9/23/2020 | 6/7/2016 | 10/22/2012 | 6/16/2008 |
|---|---|---|---|---|---|
Fund | Longitude Capital Prime Fund I | Longitude Venture Partners IV | Longitude Venture Partners III | Longitude Venture Partners II | Longitude Venture Partners |
Fund Type | |||||
Status | |||||
Amount | $135M | ||||
Sources | 1 |
Longitude Capital Service Providers
1 Service Provider
Longitude Capital has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Counsel |
Service Provider | |
|---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type |
Partnership data by VentureSource
Longitude Capital Team
13 Team Members
Longitude Capital has 13 team members, including current Founder, Managing Director, Juliet Tammenoms Bakker.
Name | Work History | Title | Status |
|---|---|---|---|
Juliet Tammenoms Bakker | Pequot Capital Mangement | Founder, Managing Director | Current |
David J. Hirsch | Pequot Capital Mangement, and McKinsey & Company | Founder, Managing Director | Current |
Sandip Agarwala | Auven Therapeutics, The Boston Consulting Group, and HealthCare Royalty Partners | Managing Director | Current |
Patrick Enright | Pequot Capital Mangement | Managing Director | Current |
Doug Foster | Managing Director | Current |
Name | Juliet Tammenoms Bakker | David J. Hirsch | Sandip Agarwala | Patrick Enright | Doug Foster |
|---|---|---|---|---|---|
Work History | Pequot Capital Mangement | Pequot Capital Mangement, and McKinsey & Company | Auven Therapeutics, The Boston Consulting Group, and HealthCare Royalty Partners | Pequot Capital Mangement | |
Title | Founder, Managing Director | Founder, Managing Director | Managing Director | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.